Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Alternative Prophylaxis in Female Recurrent Urinary Tract Infections — Stella

Home/Urinary Tract Infections/Alternative Prophylaxis in Female Recurrent Urinary Tract Infections

View on ClinicalTrials.gov

Recruiting

Back to Urinary Tract Infections trials

Alternative Prophylaxis in Female Recurrent Urinary Tract Infections

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

Switzerland

Department of Gynecology, University Hospital Basel, Basel

Department of Urology, University Hospital Basel, Basel

Key details

Phase

Post-approval study

Sponsor

University Hospital, Basel, Switzerland

Collaborators

IBSA Institut Biochimique SA

Enrollment target

~50 participants

Started

October 2020

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Sex

Female only

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.